Potassium Chloride Solution
NDC Package 33342-511-73
Package Information
Potassium Chloride solution is a medication a mineral supplement used to treat or prevent low amounts of potassium in the blood. This formulation utilizes a solution delivery system. Marketed by Macleods Pharmaceuticals Limited, this product is identified by NDC 33342-511 and is authorized under FDA application ANDA218733.
Identification & Billing
- RxCUI: 312515 - potassium chloride 20 MEQ in 15 mL Oral Solution
- RxCUI: 312515 - potassium chloride 1.33 MEQ/ML Oral Solution
- RxCUI: 312515 - K+ Chloride 1.33 MEQ/ML Oral Solution
- RxCUI: 312515 - Pot Chloride 1.33 MEQ/ML Oral Solution
- RxCUI: 312515 - potassium chloride 1.5 GM per 15 ML Oral Solution
Clinical Specifications
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 33342 - Macleods Pharmaceuticals Limited
- 33342-511 - Potassium Chloride
- 33342-511-73 - 473 mL in 1 BOTTLE
- 33342-511 - Potassium Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 33342-511-73 identifies a specific commercial package of 473 ml in 1 bottle of Potassium Chloride, a human prescription drug labeled by Macleods Pharmaceuticals Limited. This solution is formulated for oral use and contains potassium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Macleods Pharmaceuticals Limited on May 26, 2023. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics.
How is this Macleods Pharmaceuticals Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 33342051173. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.